Vitamin D-Binding Protein Directs Monocyte Responses to 25-Hydroxy- and 1,25-Dihydroxyvitamin D
Author(s) -
Rene F. Chun,
Anna Lis Lauridsen,
Lizabeth Suon,
Lee A. Zella,
J. Wesley Pike,
Robert L. Modlin,
Adrian R. Martineau,
Robert J. Wilkinson,
John S. Adams,
Martin Hewison
Publication year - 2010
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2010-0195
Subject(s) - cathelicidin , monocyte , vitamin d and neurology , intracrine , chemistry , vitamin d binding protein , vitamin , biochemistry , antimicrobial peptides , biology , endocrinology , immunology , receptor , peptide , paracrine signalling
Serum 25-hydroxyvitamin D (25OHD) is a key factor in determining monocyte induction of the antimicrobial protein cathelicidin, which requires intracrine conversion of 25OHD to 1,25-dihydroxyvitamin D [1,25(OH)(2)D]. Both vitamin D metabolites circulate bound to vitamin D-binding protein (DBP), but the effect of this on induction of monocyte cathelicidin remains unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom